{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T02:30:57Z","timestamp":1782786657355,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Hacettepe University Scientific Research Project","award":["TSA\u20102021\u201019526"],"award-info":[{"award-number":["TSA\u20102021\u201019526"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-024-05479-6","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T14:02:00Z","timestamp":1709388120000},"page":"2333-2342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Galectin-3 levels in children with cystic fibrosis"],"prefix":"10.1007","volume":"183","author":[{"given":"Dilber","family":"Ademhan Tural","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagehan","family":"Emiralioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senay","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didem","family":"Alboga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beste","family":"Ozsezen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halime","family":"Nayir Buyuksahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Guzelkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Kasikci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birce","family":"Sunman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irem","family":"Gungor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Dogru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nural","family":"Kiper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Haydar","family":"Demirel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugur","family":"Ozcelik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,2]]},"reference":[{"key":"5479_CR1","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","volume":"397","author":"M Shteinberg","year":"2021","unstructured":"Shteinberg M, Haq IJ, Polineni D, Davies JC (2021) Cystic fibrosis. Lancet 397:2195\u20132211. https:\/\/doi.org\/10.1016\/S0140-6736(20)32542-3","journal-title":"Lancet"},{"issue":"Suppl 40","key":"5479_CR2","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1002\/ppul.23242","volume":"50","author":"DP Nichols","year":"2015","unstructured":"Nichols DP, Chmiel JF (2015) Inflammation and its genesis in cystic fibrosis. Pediatr Pulmonol 50(Suppl 40):S39-56. https:\/\/doi.org\/10.1002\/ppul.23242","journal-title":"Pediatr Pulmonol"},{"key":"5479_CR3","first-page":"2205","volume-title":"The lung: scientific foundations","year":"1997","unstructured":"McElvaney NG, Proteases CRG, lung injury. In: Crystal RG, West JB, Weibel ER, Barnes PJ, (eds) (1997) The lung: scientific foundations. Lippincott-Raven, Philadelphia, PA, pp 2205\u20132218"},{"issue":"6B","key":"5479_CR4","doi-asserted-by":"publisher","first-page":"8S","DOI":"10.1016\/s0002-9343(99)80304-0","volume":"99","author":"RA Stockley","year":"1995","unstructured":"Stockley RA (1995) Role of inflammation in respiratory tract infections. Am J Med 99(6B):8S-13S. https:\/\/doi.org\/10.1016\/s0002-9343(99)80304-0","journal-title":"Am J Med"},{"key":"5479_CR5","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.chom.2016.10.003","volume":"20","author":"K Chen","year":"2016","unstructured":"Chen K, Eddens T, Trevejo-Nunez G et al (2016) IL-17 receptor signaling in the lung epithelium is required for mucosal chemokine gradients and pulmonary host defense against K. pneumoniae. Cell Host Microbe 20:596\u2013605. https:\/\/doi.org\/10.1016\/j.chom.2016.10.003","journal-title":"Cell Host Microbe"},{"key":"5479_CR6","doi-asserted-by":"publisher","first-page":"1900716","DOI":"10.1183\/13993003.00716-2019","volume":"57","author":"M Hagner","year":"2021","unstructured":"Hagner M, Albrecht M, Guerra M et al (2021) IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease. Eur Respir J 57:1900716. https:\/\/doi.org\/10.1183\/13993003.00716-2019","journal-title":"Eur Respir J"},{"issue":"2","key":"5479_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1164\/rccm.201102-0236OC","volume":"184","author":"HL Tan","year":"2011","unstructured":"Tan HL, Regamey N, Brown S, Bush A, Lloyd CM, Davies JC (2011) The Th17 pathway in cystic fibrosis lung disease. Am J Respir Crit Care Med 184(2):252\u2013258. https:\/\/doi.org\/10.1164\/rccm.201102-0236OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"5479_CR8","doi-asserted-by":"publisher","first-page":"jcs.208884","DOI":"10.1242\/jcs.208884","volume":"131","author":"L Johannes","year":"2018","unstructured":"Johannes L, Jacob R, Leffler H (2018) Galectins at a glance. J Cell Sci 131(9):jcs.208884. https:\/\/doi.org\/10.1242\/jcs.208884","journal-title":"J Cell Sci"},{"issue":"2","key":"5479_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3390\/ijms19020379","volume":"19","author":"S Sciacchitano","year":"2018","unstructured":"Sciacchitano S, Lavra L, Morgante A et al (2018) Galectin-3: one molecule for an alphabet of diseases, from A to Z. Int J Mol Sci 19(2):379. https:\/\/doi.org\/10.3390\/ijms19020379","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5479_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.bbamcr.2015.08.008","volume":"1863","author":"PP Ruvolo","year":"2016","unstructured":"Ruvolo PP (2016) Galectin 3 as a guardian of the tumor microenvironment. Biochim Biophys Acta 1863(3):427\u2013437. https:\/\/doi.org\/10.1016\/j.bbamcr.2015.08.008","journal-title":"Biochim Biophys Acta"},{"key":"5479_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.numecd.2008.06.006","volume":"18","author":"G Pugliese","year":"2008","unstructured":"Pugliese G (2008) Do advanced glycation end products contribute to the development of long-term diabetic complications? Nutr Metab Cardiovasc Dis 18:457\u2013460. https:\/\/doi.org\/10.1016\/j.numecd.2008.06.006","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"5479_CR12","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.ijcard.2014.08.011","volume":"176","author":"Gonz\u0384alez GE, Cassaglia P, Truant S","year":"2014","unstructured":"Gonz\u0384alez GE, Cassaglia P, Truant SN (2014) Galectin-3 is essential for early wound healing and ventricular remodelling after myocardial infarction in mice. Int J Cardiol 176:1423\u20131425. https:\/\/doi.org\/10.1016\/j.ijcard.2014.08.011","journal-title":"Int J Cardiol"},{"key":"5479_CR13","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.3390\/ijms21145097","volume":"21","author":"A Arsenijevic","year":"2020","unstructured":"Arsenijevic A, Stojanovic B, Milovanovic J, Arsenijevic D, Arsenijevic N, Milovanovic M (2020) Galectin-3 in inflammasome activation and primary biliary cholangitis development. Int J Mol Sci 21:5097. https:\/\/doi.org\/10.3390\/ijms21145097","journal-title":"Int J Mol Sci"},{"key":"5479_CR14","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.cca.2020.07.040","volume":"510","author":"X Han","year":"2020","unstructured":"Han X, Zhang S, Chen Z et al (2020) Cardiac biomarkers of heart failure in chronic kidney disease. Clin Chim Acta 510:298\u2013310. https:\/\/doi.org\/10.1016\/j.cca.2020.07.040","journal-title":"Clin Chim Acta"},{"key":"5479_CR15","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3390\/ijms18050973","volume":"18","author":"I Fort-Gallifa","year":"2017","unstructured":"Fort-Gallifa I, Hern\u00e1ndez-Aguilera A, Garc\u00eda-Heredia A et al (2017) Galectin-3 in peripheral artery disease Relationships with markers of oxidative stress and inflammation. Int J Mol Sci 18:973. https:\/\/doi.org\/10.3390\/ijms18050973","journal-title":"Int J Mol Sci"},{"key":"5479_CR16","doi-asserted-by":"publisher","first-page":"155635","DOI":"10.1016\/j.cyto.2021.155635","volume":"146","author":"GF Bouvet","year":"2021","unstructured":"Bouvet GF, Bulka O, Coriati A et al (2021) Peripheral blood mononuclear cell response to YKL-40 and Galectin-3 in cystic fibrosis. Cytokine 146:155635. https:\/\/doi.org\/10.1016\/j.cyto.2021.155635","journal-title":"Cytokine"},{"key":"5479_CR17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/s0022-3476(98)70344-0","volume":"132","author":"BJ Rosenstein","year":"1998","unstructured":"Rosenstein BJ, Cutting GR (1998) The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 132:589\u2013595. https:\/\/doi.org\/10.1016\/s0022-3476(98)70344-0","journal-title":"J Pediatr"},{"key":"5479_CR18","unstructured":"Cystic Fibrosis Mutation Database.\u00a0http:\/\/www.genet.sickkids.on.ca\/cftr\/Home.html.\u00a0Accessed 5 Mar 2023"},{"issue":"1","key":"5479_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1569-1993(02)00141-8","volume":"2","author":"TWR Lee","year":"2003","unstructured":"Lee TWR, Brownlee KG, Conway SP et al (2003) Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2(1):29\u201334. https:\/\/doi.org\/10.1016\/S1569-1993(02)00141-8","journal-title":"J Cyst Fibros"},{"issue":"2","key":"5479_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V et al (2005) Standardization of spirometry. Eur Respir J 26(2):319\u2013338. https:\/\/doi.org\/10.1183\/09031936.05.00034805","journal-title":"Eur Respir J"},{"issue":"6","key":"5479_CR21","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1183\/09031936.00080312","volume":"40","author":"PH Quanjer","year":"2012","unstructured":"Quanjer PH, Stanojevic S, Cole TJ et al (2012) Multi-ethnic reference values for spirometry for the 3\u201395-yr age range: the global lung function 2012 equations. Eur Respir J 40(6):1324\u20131343. https:\/\/doi.org\/10.1183\/09031936.00080312","journal-title":"Eur Respir J"},{"key":"5479_CR22","unstructured":"Schloerke B, Cook D, Larmarange J (2021) GGally: extension to \u2018ggplot2\u2019. R package version 2.1.2. https:\/\/CRAN.R-project.org\/package=GGally"},{"issue":"9","key":"5479_CR23","doi-asserted-by":"publisher","first-page":"e24399","DOI":"10.1371\/journal.pone.0024399","volume":"6","author":"A Hector","year":"2011","unstructured":"Hector A, Kormann MS, Mack I et al (2011) The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease. PLoS ONE 6(9):e24399. https:\/\/doi.org\/10.1371\/journal.pone.0024399","journal-title":"PLoS ONE"},{"issue":"5","key":"5479_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jcf.2015.12.020","volume":"15","author":"S Leonardi","year":"2016","unstructured":"Leonardi S, Parisi GF, Capizzi A et al (2016) YKL-40 as marker of severe lung disease in cystic fibrosis patients. J Cyst Fibros 15(5):583\u2013586. https:\/\/doi.org\/10.1016\/j.jcf.2015.12.020","journal-title":"J Cyst Fibros"},{"key":"5479_CR25","doi-asserted-by":"publisher","first-page":"156038","DOI":"10.1016\/j.cyto.2022.156038","volume":"160","author":"M Ghorban Movahed","year":"2022","unstructured":"Ghorban Movahed M, Abdi Ali A, Ghazanfari T, Modaresi M (2022) Cytokine patterns in cystic fibrosis patients with different microbial infections in oropharyngeal samples. Cytokine 160:156038. https:\/\/doi.org\/10.1016\/j.cyto.2022.156038","journal-title":"Cytokine"},{"issue":"4","key":"5479_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1756-185X.2011.01632.x","volume":"14","author":"MH Ezzat","year":"2011","unstructured":"Ezzat MH, El-Gammasy TM, Shaheen KY, Osman AO (2011) Elevated production of galectin-3 is correlated with juvenile idiopathic arthritis disease activity, severity, and progression. Int J Rheum Dis 14(4):345\u2013352. https:\/\/doi.org\/10.1111\/j.1756-185X.2011.01632.x","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"5479_CR27","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3892\/ijmm.2017.3311","volume":"41","author":"R Dong","year":"2018","unstructured":"Dong R, Zhang M, Hu Q et al (2018) Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy. Int J Mol Med 41(2):599\u2013614. https:\/\/doi.org\/10.3892\/ijmm.2017.3311","journal-title":"Int J Mol Med"},{"issue":"4","key":"5479_CR28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2217\/mm-2015-0044","volume":"10","author":"C Caselli","year":"2016","unstructured":"Caselli C, Ragusa R, Prontera C et al (2016) Distribution of circulating cardiac biomarkers in healthy children: from birth through adulthood. Biomark Med 10(4):357\u2013365. https:\/\/doi.org\/10.2217\/mm-2015-0044","journal-title":"Biomark Med"},{"issue":"12","key":"5479_CR29","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s40618-016-0515-8","volume":"39","author":"J Pang","year":"2016","unstructured":"Pang J, Nguyen VT, Rhodes DH, Sullivan ME, Braunschweig C, Fantuzzi G (2016) Relationship of galectin-3 with obesity, IL-6, and CRP in women. J Endocrinol Invest 39(12):1435\u20131443. https:\/\/doi.org\/10.1007\/s40618-016-0515-8","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"5479_CR30","doi-asserted-by":"publisher","first-page":"e001894","DOI":"10.1136\/bmjdrc-2020-001894","volume":"9","author":"S Zhen","year":"2021","unstructured":"Zhen S, Ma Y, Han Y, Zhao Z, Yang X, Wen D (2021) Serum galectin-3BP as a novel marker of obesity and metabolic syndrome in Chinese adolescents. BMJ Open Diabetes Res Care 9(1):e001894. https:\/\/doi.org\/10.1136\/bmjdrc-2020-001894","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"12","key":"5479_CR31","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.jacc.2020.07.044","volume":"76","author":"N Suthahar","year":"2020","unstructured":"Suthahar N, Lau ES, Blaha MJ et al (2020) Sex-specific associations of cardiovascular risk factors and biomarkers with incident heart failure. J Am Coll Cardiol 76(12):1455\u20131465. https:\/\/doi.org\/10.1016\/j.jacc.2020.07.044","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"5479_CR32","doi-asserted-by":"publisher","first-page":"e28310","DOI":"10.7759\/cureus.28310","volume":"14","author":"A Khadeja Bi","year":"2022","unstructured":"Khadeja Bi A, Santhosh V, Sigamani K (2022) Levels of Galectin-3 in chronic heart failure: a case-control study. Cureus 14(8):e28310. https:\/\/doi.org\/10.7759\/cureus.28310","journal-title":"Cureus"},{"key":"5479_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1365-2796.2011.02476.x","volume":"272","author":"RA de Boer","year":"2012","unstructured":"de Boer RA, van Veldhuisen DJ, Gansevoort RT et al (2012) The fibrosis marker galectin-3 and outcome in the general population. J Intern Med 272:55\u201364. https:\/\/doi.org\/10.1111\/j.1365-2796.2011.02476.x","journal-title":"J Intern Med"},{"issue":"1","key":"5479_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1164\/rccm.201509-1753OC","volume":"194","author":"JE Ho","year":"2016","unstructured":"Ho JE, Gao W, Levy D et al (2016) Galectin-3 is associated with restrictive lung disease and interstitial lung abnormalities. Am J Respir Crit Care Med 194(1):77\u201383. https:\/\/doi.org\/10.1164\/rccm.201509-1753OC","journal-title":"Am J Respir Crit Care Med"},{"key":"5479_CR35","doi-asserted-by":"publisher","first-page":"103546","DOI":"10.1016\/j.resp.2020.103546","volume":"282","author":"M d'Alessandro","year":"2020","unstructured":"d\u2019Alessandro M, De Vita E, Bergantini L et al (2020) Galactin-1, 3 and 9: potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases. Respir Physiol Neurobiol 282:103546. https:\/\/doi.org\/10.1016\/j.resp.2020.103546","journal-title":"Respir Physiol Neurobiol"},{"issue":"3","key":"5479_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00408-021-00449-3","volume":"199","author":"M d'Alessandro","year":"2021","unstructured":"d\u2019Alessandro M, Bergantini L, Fossi A et al (2021) The role of galectins in chronic lung allograft dysfunction. Lung 199(3):281\u2013288. https:\/\/doi.org\/10.1007\/s00408-021-00449-3","journal-title":"Lung"},{"key":"5479_CR37","doi-asserted-by":"publisher","first-page":"4612","DOI":"10.12659\/msm.903472","volume":"23","author":"W Feng","year":"2017","unstructured":"Feng W, Wu X, Li S et al (2017) Association of serum Galectin-3 with the acute exacerbation of chronic obstructive pulmonary disease. Med Sci Monit 23:4612\u20134618. https:\/\/doi.org\/10.12659\/msm.903472","journal-title":"Med Sci Monit"}],"updated-by":[{"DOI":"10.1007\/s00431-024-05585-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000}}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-024-05479-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-024-05479-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-024-05479-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T07:04:51Z","timestamp":1716015891000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-024-05479-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,2]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["5479"],"URL":"https:\/\/doi.org\/10.1007\/s00431-024-05479-6","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00431-024-05585-5","asserted-by":"object"}]},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,2]]},"assertion":[{"value":"8 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00431-024-05585-5","URL":"https:\/\/doi.org\/10.1007\/s00431-024-05585-5","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted after approval from the institutional research and ethical committee (GO 21\/392) and according to the Helsinki Declaration of Human Rights guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}